The Effect On Self-Care and Self-Efficacy of Inhaler Training in COPD
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 67
- 试验地点
- 2
- 主要终点
- Self-Care Agency Scale
研究概览
简要总结
This study aims to evaluate the effect of planned inhaler medication training on self-care agency and self-efficacy level.
详细描述
Pulmonary diseases are a major source of mortality and morbidity globally. The major symptom of COPD is dyspnea. Since dyspnea leads to activity limitation and inadequate self-care skills among individuals, it is often associated with major psychological comorbidity, social isolation and poor perceived quality of life. COPD patients with high self-efficacy are high enough to level of treatment adherence. On the other hand, the most preferred treatment method for the management and mitigation of COPD symptoms is by the use of inhaler medication. However, incorrect use of the inhaler would lead to failure in the control of COPD patients. Also, it fails to provide COPD patients with self-care agency and self-efficacy levels. In COPD, planned inhaler medication training has been shown in many studies to reduce dyspnoea, increase self-care and self-efficacy levels. Therefore, planned inhaler medication training increases quality of life in COPD patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who are literate,
- •Diagnosed with COPD at least six months ago,
- •Using inhaler medication since three or more months,
- •Moderate or severe COPD, according to GOLD criteria,
- •Incorrect use inhaler medication uses according to the list of inhaler medication use skills,
- •No communication problems,
- •No mental confusion or any psychiatric problem,
- •Agrees to participate in the study.
排除标准
- •Cognitive dysfunction,
- •Severe pulmonary, cardiological or malignant disease,
- •In a period of exacerbation,
- •Correctly performs all steps for their prescribed inhaler medication(s), according to the list of inhaler skills.
结局指标
主要结局
Self-Care Agency Scale
时间窗: baseline to the 3 months after intervention
The Self-care Agency Scale (1979) was developed by Kearney and Fleischer, and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. With this scale consisting of 35 items, patients evaluate their ability or agency to perform self-care actions.
COPD Self-Efficacy Scale (CSES)
时间窗: baseline to the 3 months after intervention
CSES developed by Wigal et al. (1991) is used to determine the degree of confidence that COPD patients have in managing or avoiding breathing difficulty during certain activities. The scale consists of 34 items and 5 subscales.
次要结局
- Medical Research Council (MRC) Dyspnea Scale(baseline to the 3 months after intervention)
- Modified Borg Dyspnea Scale(baseline to the 3 months after intervention)
研究者
Gamze MUZ
Assistant Professor
Nevsehir Haci Bektas Veli University